Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 2 (2005), Issue 4 (April)

1. Cytogenetic analysis of 52 Indian patients with de novo myelodysplastic syndromes-a comparative analysis of results with reports from Asia.
   Ann Hematol, 84(5): 298-303. [Abstract] [Full-text]
2. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
   Blood, 105(8): 3051-7. [Abstract] [Full-text]
3. Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.
   Blood, 105(8): 3058-65. [Abstract] [Full-text]
4. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
   Ann Hematol, 84(5): 287-97. [Abstract] [Full-text]
5. A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia.
   Cancer Res, 65(7): 2890-8. [Abstract] [Full-text]
6. The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
   Cancer Res, 65(7): 2662-7. [Abstract] [Full-text]
7. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
   Cancer Res, 65(7): 2537-41. [Abstract] [Full-text]
8. Excess mortality, length of stay, and costs associated with serious fungal infections among elderly cancer patients: findings from linked SEER-Medicare data.
   Value Health, 8(2): 140-8. [Abstract] [Full-text]
9. Secondary malignancies and quality of life after stem cell transplantation.
   Bone Marrow Transplant, 35: S83-7. [Abstract] [Full-text]
10. Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
    Bone Marrow Transplant, 35(8): 767-73. [Abstract] [Full-text]
11. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.
    J Clin Microbiol, 43(4): 1818-28. [Abstract] [Full-text]
12. Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis.
    Clin Cancer Res, 11(7): 2540-6. [Abstract] [Full-text]
13. Influential factors for the collection of peripheral blood stem cells and engraftment in acute myeloid leukemia patients in first complete remission.
    Int J Hematol, 81(3): 258-63. [Abstract] [Full-text]
14. Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experience.
    Eur J Haematol, 74(5): 418-23. [Abstract] [Full-text]
15. Diagnosis of malignancies in children with musculoskeletal complaints.
    Sao Paulo Med J, 123(1): 21-3. [Abstract] [Full-text]
16. Identification of NOM1, a nucleolar, eIF4A binding protein encoded within the chromosome 7q36 breakpoint region targeted in cases of pediatric acute myeloid leukemia.
    Gene, 347(1): 137-45. [Abstract] [Full-text]
17. The common viral insertion site Evi12 is located in the 5'-noncoding region of Gnn, a novel gene with enhanced expression in two subclasses of human acute myeloid leukemia.
    J Virol, 79(9): 5249-58. [Abstract] [Full-text]
18. Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.
    Cancer, 103(8): 1652-8. [Abstract] [Full-text]
19. Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells.
    Oncogene, 24(16): 2739-44. [Abstract] [Full-text]
20. SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells.
    Oncogene, 24(16): 2625-34. [Abstract] [Full-text]
21. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases.
    Mol Cell Biol, 25(9): 3690-703. [Abstract] [Full-text]
22. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.
    J Cell Biochem, 95(2): 339-51. [Abstract] [Full-text]
23. Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemia.
    Clin Cancer Res, 11(8): 2998-3008. [Abstract] [Full-text]
24. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.
    Cancer Cell, 7(4): 351-62. [Abstract] [Full-text]
25. Reverse recruitment: the Nup84 nuclear pore subcomplex mediates Rap1/Gcr1/Gcr2 transcriptional activation.
    Proc Natl Acad Sci U S A, 102(16): 5749-54. [Abstract] [Full-text]
26. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
    J Clin Invest, 115(4): 919-29. [Abstract] [Full-text]
27. One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.
    Br J Haematol, 129(3): 403-10. [Abstract] [Full-text]
28. Fatal Blastoschizomyces capitatus sepsis in a neutropenic patient with acute myeloid leukemia: first documented case from Greece.
    Mycoses, 48(3): 216-20. [Abstract] [Full-text]
29. T-cell lymphoblastic leukemia/lymphoma syndrome with eosinophilia and acute myeloid leukemia.
    Cytometry B Clin Cytom, 65(1): 37-41. [Abstract] [Full-text]
30. Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms.
    Blood, 105(9): 3714-21. [Abstract] [Full-text]
31. Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.
    Blood, 105(9): 3615-22. [Abstract] [Full-text]
32. Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction.
    Blood, 105(9): 3699-706. [Abstract] [Full-text]
33. A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome.
    Blood, 105(9): 3731-6. [Abstract] [Full-text]
34. FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L).
    Blood, 105(9): 3679-85. [Abstract] [Full-text]
35. Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
    Blood, 105(9): 3420-7. [Abstract] [Full-text]
36. Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells.
    EMBO J, 24(6): 1232-42. [Abstract] [Full-text]
37. hDOT1L links histone methylation to leukemogenesis.
    Cell, 121(2): 167-78. [Abstract] [Full-text]
38. Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells.
    Exp Hematol, 33(5): 558-63. [Abstract] [Full-text]
39. Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation.
    Leukemia, 19(5): 814-21. [Abstract] [Full-text]
40. Animal models of acute myelogenous leukaemia - development, application and future perspectives.
    Leukemia, 19(5): 687-706. [Abstract] [Full-text]
41. Nonrandom aneuploidy of chromosomes 1, 5, 6, 7, 8, 9, 11, 12, and 21 induced by the benzene metabolites hydroquinone and benzenetriol.
    Environ Mol Mutagen, 45(4): 388-96. [Abstract] [Full-text]
42. Immunophenotype of down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Klin Padiatr, 217(3): 126-34. [Abstract] [Full-text]
43. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Am J Hematol, 79(1): 26-35. [Abstract] [Full-text]
44. RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient.
    Am J Hematol, 79(1): 43-5. [Abstract] [Full-text]
45. Alteration of p73 in acute myelogenous leukemia.
    Am J Hematol, 79(1): 1-7. [Abstract] [Full-text]
46. Granulocytic sarcoma presenting as bilateral adrenal masses.
    Am J Hematol, 79(1): 73-5. [Abstract] [Full-text]
47. The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor.
    Development, 132(10): 2263-72. [Abstract] [Full-text]
48. A variant t(8;10;21) in a patient with pathological features mimicking atypical chronic myeloid leukemia.
    Cancer Genet Cytogenet, 159(1): 79-83. [Abstract] [Full-text]
49. Corneal pseudomembrane from acute inflammatory response and fibrin formation to acute myeloid leukemic infiltrate.
    Am J Ophthalmol, 139(5): 921-3. [Abstract] [Full-text]
50. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA.
    Leukemia, 19(4): 636-43. [Abstract] [Full-text]
51. Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience.
    Leukemia, 19(4): 537-44. [Abstract] [Full-text]

© 2004-2012 Acute Myeloid Leukemia Research Today. All Rights Reserved.